Werewolf Therapeutics HOWL
NASDAQ HOWL
$1.00 0.00 (-0.49%)
As of: Oct 23, 2026 · 3:17 PM EDT

Werewolf Therapeutics (HOWL) EBT Margin (2022 - 2026)

Updated

Werewolf Therapeutics (HOWL) recorded EBT Margin of 33.14% in Q2 2026.

Analysis

Werewolf Therapeutics (HOWL) EBT Margin (2022 - 2026) Analysis & Trends

On a TTM basis, Werewolf Therapeutics' EBT Margin came in at -161.14% as of Jun 30, 2026, up 488678.86 percentage points year-over-year; for FY2024, it was -3767.21%, down 3585.56 percentage points from FY2023.

  • Across earlier years, EBT Margin came in at -181.65% in FY2023 (+148.50 pp) and -330.15% in FY2022.
  • The Q2 2026 figure is the highest quarterly EBT Margin in data going back to Q2 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Eli Lilly 1,131.67 Bn 1,100.25 Bn 19.71 Bn 40.25%
2 Johnson & Johnson 635.68 Bn 555.54 Bn 17.30 Bn 0.13%
3 AbbVie 504.96 Bn 478.07 Bn 12.70 Bn 25.18%
4 Merck 357.95 Bn 312.33 Bn 12.21 Bn -4.11%
5 Novartis Ag 290.91 Bn 254.90 Bn 11.24 Bn 29.63%
6 Astrazeneca 265.07 Bn 238.76 Bn 12.86 Bn 18.19%
7 Amgen 237.58 Bn 192.98 Bn 7.24 Bn 27.53%
8 Gilead Sciences 194.90 Bn 169.10 Bn 6.22 Bn -131.41%
9 Pfizer 171.11 Bn 117.76 Bn 10.94 Bn -4.34%
10 Werewolf Therapeutics 48.84 Mn -142.42 Mn - 33.14%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 33.14%
Dec 31, 2024 -135,373.33%
Jun 30, 2024 -1,601.84%
Mar 31, 2024 -2,182.21%
Dec 31, 2023 -799.27%
Sep 30, 2023 -140.41%
Jun 30, 2023 -62.78%
Mar 31, 2023 -243.64%
Dec 31, 2022 -164.77%
Sep 30, 2022 -240.36%
Jun 30, 2022 -358.61%
API Access

Werewolf Therapeutics EBT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt-margin&ticker=HOWL&period=max&api_key=YOUR_API_KEY